Home NDC 67184-0533-3 imatinib mesylate
Product NDC 67184-0533
Requested package NDC 67184-0533-3
11-digit product format 671840533
Labeler code 67184
Product ID 67184-0533_a41dbedd-ee4e-401c-b446-a435929ff903
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name imatinib mesylate
Dosage form TABLET
Route ORAL
Labeler Qilu Pharmaceutical Co., Ltd.
Application ANDA212135
Marketing category ANDA
Marketing start 2022-06-21
Substance IMATINIB MESYLATE
Active strength 400 mg/1
Pharmacologic classes Bcr-Abl Tyrosine Kinase Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A212135-001 IMATINIB MESYLATE IMATINIB MESYLATE EQ 100MG BASE TABLET / ORAL AB 2022-06-21 A212135-002 IMATINIB MESYLATE IMATINIB MESYLATE EQ 400MG BASE TABLET / ORAL AB 2022-06-21
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 56 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A212135-001 IMATINIB MESYLATE EQ 100MG BASE TABLET / ORAL AB 2022-06-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A212135-002 IMATINIB MESYLATE EQ 400MG BASE TABLET / ORAL AB 2022-06-21 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A212135-001 IMATINIB MESYLATE EQ 100MG BASE TABLET / ORAL AB 2022-06-21 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A212135-002 IMATINIB MESYLATE EQ 400MG BASE TABLET / ORAL AB 2022-06-21 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A212135-001 IMATINIB MESYLATE EQ 100MG BASE TABLET / ORAL AB 2022-06-21 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A212135-002 IMATINIB MESYLATE EQ 400MG BASE TABLET / ORAL AB 2022-06-21 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A212135-001 IMATINIB MESYLATE EQ 100MG BASE TABLET / ORAL AB 2022-06-21 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A212135-002 IMATINIB MESYLATE EQ 400MG BASE TABLET / ORAL AB 2022-06-21 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A212135-001 IMATINIB MESYLATE EQ 100MG BASE TABLET / ORAL AB 2022-06-21 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A212135-002 IMATINIB MESYLATE EQ 400MG BASE TABLET / ORAL AB 2022-06-21 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A212135-001 IMATINIB MESYLATE EQ 100MG BASE TABLET / ORAL AB 2022-06-21 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A212135-002 IMATINIB MESYLATE EQ 400MG BASE TABLET / ORAL AB 2022-06-21 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A212135-001 IMATINIB MESYLATE EQ 100MG BASE TABLET / ORAL AB 2022-06-21 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A212135-002 IMATINIB MESYLATE EQ 400MG BASE TABLET / ORAL AB 2022-06-21 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A212135-001 IMATINIB MESYLATE EQ 100MG BASE TABLET / ORAL AB 2022-06-21 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A212135-002 IMATINIB MESYLATE EQ 400MG BASE TABLET / ORAL AB 2022-06-21 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A212135-001 IMATINIB MESYLATE EQ 100MG BASE TABLET / ORAL AB 2022-06-21 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A212135-002 IMATINIB MESYLATE EQ 400MG BASE TABLET / ORAL AB 2022-06-21 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A212135-001 IMATINIB MESYLATE EQ 100MG BASE TABLET / ORAL AB 2022-06-21 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A212135-002 IMATINIB MESYLATE EQ 400MG BASE TABLET / ORAL AB 2022-06-21 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A212135-001 IMATINIB MESYLATE EQ 100MG BASE TABLET / ORAL AB 2022-06-21 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A212135-002 IMATINIB MESYLATE EQ 400MG BASE TABLET / ORAL AB 2022-06-21 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A212135-001 IMATINIB MESYLATE EQ 100MG BASE TABLET / ORAL AB 2022-06-21 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A212135-002 IMATINIB MESYLATE EQ 400MG BASE TABLET / ORAL AB 2022-06-21 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A212135-001 IMATINIB MESYLATE EQ 100MG BASE TABLET / ORAL AB 2022-06-21 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A212135-002 IMATINIB MESYLATE EQ 400MG BASE TABLET / ORAL AB 2022-06-21 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A212135-001 IMATINIB MESYLATE EQ 100MG BASE TABLET / ORAL AB 2022-06-21 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A212135-002 IMATINIB MESYLATE EQ 400MG BASE TABLET / ORAL AB 2022-06-21 8072bd15b7f6…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A212135-001 IMATINIB MESYLATE EQ 100MG BASE TABLET / ORAL AB 2022-06-21 6a51e52b5d6a…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A212135-002 IMATINIB MESYLATE EQ 400MG BASE TABLET / ORAL AB 2022-06-21 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A212135-001 IMATINIB MESYLATE EQ 100MG BASE TABLET / ORAL AB 2022-06-21 1c564ffb4f44…2024-02-18 07:12 UTC 2024-02 A212135-002 IMATINIB MESYLATE EQ 400MG BASE TABLET / ORAL AB 2022-06-21 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A212135-001 IMATINIB MESYLATE EQ 100MG BASE TABLET / ORAL AB 2022-06-21 ea1830bbd6c7…2023-12-20 04:57 UTC 2023-12 A212135-002 IMATINIB MESYLATE EQ 400MG BASE TABLET / ORAL AB 2022-06-21 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A212135-001 IMATINIB MESYLATE EQ 100MG BASE TABLET / ORAL AB 2022-06-21 a72a2bbeb626…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A212135-002 IMATINIB MESYLATE EQ 400MG BASE TABLET / ORAL AB 2022-06-21 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A212135-001 IMATINIB MESYLATE EQ 100MG BASE TABLET / ORAL AB 2022-06-21 9b2671bbb829…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A212135-002 IMATINIB MESYLATE EQ 400MG BASE TABLET / ORAL AB 2022-06-21 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A212135-001 IMATINIB MESYLATE EQ 100MG BASE TABLET / ORAL AB 2022-06-21 a67488948f0b…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A212135-002 IMATINIB MESYLATE EQ 400MG BASE TABLET / ORAL AB 2022-06-21 a67488948f0b…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 56 observed states.
openFDA label cross-check# Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
Matched openFDA labels page 1 of 1 · 3 matching rows.
Additional Listing Data#
Finished product Yes
Brand name base imatinib mesylate
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength IMATINIB MESYLATE 400 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 8A1O1M485B Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 403878 Internal RxNorm lookup 403879 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 67184-0533-1 imatinib mesylate 30 in 1 BOTTLE TABLET 30 35 67184-0533-2 imatinib mesylate 300 in 1 BOTTLE TABLET 300 35 67184-0533-3 imatinib mesylate 10 in 1 BLISTER PACK TABLET 10 35 67184-0533-3 imatinib mesylate 30 in 1 CARTON TABLET 30 35
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 67184-0533 IMATINIB MESYLATE TABLET [QILU PHARMACEUTICAL CO., LTD.] 35 Current NDC, Legacy NDC, 4 package rows 20241207_82eb01e0-8685-4f06-8a72-7663e8ded38f.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 67184-0533-3 67184053303 30 BLISTER PACK in 1 CARTON (67184-0533-3) / 10 TABLET in 1 BLISTER PACK 30 blister pack 2022-06-21 0000-00-00 No No Current